Free standard shipping on orders $300+ · Same-day dispatch before 2PM AEST
AUSTRALIAN OWNED & OPERATED
FAST DISCREET SHIPPING AUSTRALIA WIDE
LAB TESTED FOR PURITY & QUALITY
Customer Support:
contact@aussiepeptideco.com
Batch-verified · ≥99.0% purity (HPLC) Batch ZL-17-80 · Tested by Janoshik Analytical · 23/05/2026
View COA
Tissue Repair Research

KLOW Blend 80mg

Recovery research blend · KPV + GHK-Cu + BPC-157 + TB-500 (80mg)

Be the first to review SKU: APC-KLOW-BLEND-80MG
Purity
≥99.0%
Lab Tested
Third-Party
Batch Specific
COA
$189.99 AUD
In Stock
Quantity
Order within for same-day dispatch
Secure CheckoutSSL Encrypted
Fast Australia WideDiscreet Shipping
Orders before 2pm AESTDispatched Same Day

Also searched as: KLOW stack, KLOW peptide blend

Trusted Zynova Labs Supplier Genuine Zynova Labs research vials, stocked and dispatched from Melbourne.

Third-Party Tested

HPLC & mass spec verified purity

Batch Specific COA

Certificate with every batch

Discreet Packaging

Plain, unbranded, tamper-evident

Same-Day Dispatch

Before 2PM AEST, Australia-wide

KLOW is a multi-component research peptide blend formulated for laboratory investigation of cellular signalling, tissue-response pathways and related experimental mechanisms. The formulation combines KPV, BPC-157, TB-500 and GHK-Cu, bringing together compounds that have individually attracted interest across inflammation, tissue models, extracellular matrix biology and cellular repair research.

What Is KLOW?

KLOW is a pre-blended formulation containing four research compounds with distinct biological characteristics.

KPV is a short tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). Experimental research has examined KPV in relation to inflammatory signalling, including pathways associated with NF-κB activity.

BPC-157 is a synthetic peptide derived from a sequence associated with gastric proteins. Much of the available evidence is preclinical, with animal and laboratory models investigating angiogenesis, tissue responses and cellular signalling.

TB-500 is a synthetic peptide related to thymosin beta-4 research. Thymosin beta-4 has been investigated for its relationship with actin regulation, cell migration and tissue-remodelling processes.

GHK-Cu is a naturally occurring copper-binding tripeptide complex. Research has explored its involvement in extracellular matrix regulation, collagen-related processes, gene expression and cellular responses.

Combining these compounds allows researchers to examine several biological pathways within a single experimental formulation.

KLOW is supplied as a lyophilised research material for controlled laboratory studies. It is intended exclusively for scientific and analytical research and should not be interpreted as a medicine or therapeutic product.

ManufacturerZynova Labs
Strength80mg
Purity≥99.0% (HPLC, batch ZL-17-80)
AppearanceWhite lyophilised powder
FormLyophilised Powder
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryTissue Repair Research
UsageFor Research Use Only. Not for human consumption.

Key Research Areas

KLOW research may be relevant to experimental investigation involving:

Evidence differs substantially between the individual components. Findings from cell cultures or animal models should not be interpreted as established effects in humans.

Why Researchers Study KLOW

The scientific interest in KLOW comes primarily from its multi-component composition. Rather than focusing on one signalling mechanism, the formulation provides compounds associated with several different areas of experimental biology.

KPV is primarily of interest for inflammatory signalling research, while BPC-157 has been investigated extensively in preclinical tissue models. TB-500-related research focuses partly on actin-mediated processes and cellular migration, whereas GHK-Cu is associated with copper-dependent signalling and extracellular matrix research.

These complementary research areas make KLOW suitable for experimental designs examining interactions between multiple cellular pathways. This does not establish that the compounds are clinically synergistic or produce enhanced therapeutic effects.

Key Research Areas at a Glance

Cellular migration and signalling
Inflammatory-response pathways
Extracellular matrix regulation
Angiogenesis-related mechanisms
Collagen and tissue-remodelling models
Actin-associated cellular processes; and
Cellular responses to experimental tissue stress

KLOW in Australia

Researchers looking for KLOW Australia products should assess more than the stated vial strength. Batch documentation, composition, analytical testing and traceability are important considerations when comparing research materials.

Before ordering KLOW online, researchers should verify current Australian stock availability, listed price, shipping arrangements and the relevant batch CoA. Product information should clearly identify KLOW as a laboratory research material rather than a therapeutic product.

This product is intended strictly for laboratory and in-vitro research purposes. It has not been evaluated for human or veterinary use, and any information provided here is for educational reference only.

Specifications

Product NameKLOW Blend 80mg
ManufacturerZynova Labs
Strength80mg
Purity≥99.0% (HPLC, batch ZL-17-80)
AppearanceWhite lyophilised powder
FormLyophilised Powder
VialSealed, sterile glass vial
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryTissue Repair Research
TestingIndependent third-party HPLC & MS
DocumentationBatch-specific COA included
UsageFor Research Use Only. Not for human consumption.

Certificate of Analysis

Quality, Purity and Batch Testing

Researchers should evaluate KLOW using the analytical documentation supplied for the specific batch. For a blended formulation, testing is particularly important because overall purity alone does not necessarily confirm the quantity of each individual component.

Where available, HPLC and LC-MS analysis can provide information about chromatographic purity, molecular identity and composition. A batch-specific Certificate of Analysis (CoA) should be consulted to confirm the analytical specifications for the vial being studied.

Analytical purity should not be interpreted as evidence of clinical safety, efficacy or suitability for human use.

CERTIFICATE OF ANALYSIS
KLOW Blend 80mg
Batch: ZL-17-80 · 23/05/2026
Janoshik Analytical Certificate of Analysis for KLOW Blend 80mg

Storage & Handling

Storage and Laboratory Handling

  • Lyophilised storage: Follow the storage conditions stated on the product label and relevant batch documentation.
  • After reconstitution: Where validated post-reconstitution stability information is not supplied, researchers should follow their laboratory’s validated protocol and the applicable batch documentation.

Avoid assuming a specific shelf life, solvent, concentration or stability period unless it has been analytically established for the product.

Unopened VialStore at -20°C, protect from light & moisture
ReconstitutionBacteriostatic water (recommended)
After ReconstitutionRefrigerate at 2–8°C, use within 4 weeks
HandlingUse appropriate PPE and standard laboratory safety procedures
ShippingTracked, discreet delivery Australia-wide via Australia Post. Express available.

Reconstitution calculator: KLOW Blend 80mg

Work out concentration and the volume to draw for each aliquot before you add diluent.

mg
mL
Concentration
–
Volume per aliquot
–
On a 1 mL (U-100) syringe
–
Aliquots per vial
–

A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.

For Research Use Only. Not for human or veterinary consumption.

KLOW Blend 80mg: Frequently Asked Questions

KLOW is a research blend containing KPV, BPC-157, TB-500 and GHK-Cu for laboratory investigation.

Its components are studied across different pathways involving inflammatory signalling, cellular migration, extracellular matrix regulation and tissue-response mechanisms.

Their different biological research areas allow investigators to explore multiple signalling pathways within one experimental formulation.

Areas of interest include cellular signalling, inflammation, extracellular matrix biology, angiogenesis and tissue-remodelling models.

Researchers should refer to the specific product's analytical report for verified purity, identity and composition information.

Where provided, the batch-specific CoA should be checked for analytical results and composition details.

Follow the verified storage instructions supplied with the batch rather than assuming general peptide storage conditions.

Availability, pricing and domestic shipping should be confirmed directly from the Australian research supplier before ordering.

No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.

Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.

Reviews

There are no reviews yet.

Be the first to review “KLOW Blend 80mg”

Your email address will not be published. Required fields are marked *

Shopping Cart (0 items)

Your cart is empty

Add some research compounds to get started.

Browse Products